CA2366359A1 - Genes bacteriens essentiels et leurs proteines - Google Patents

Genes bacteriens essentiels et leurs proteines Download PDF

Info

Publication number
CA2366359A1
CA2366359A1 CA002366359A CA2366359A CA2366359A1 CA 2366359 A1 CA2366359 A1 CA 2366359A1 CA 002366359 A CA002366359 A CA 002366359A CA 2366359 A CA2366359 A CA 2366359A CA 2366359 A1 CA2366359 A1 CA 2366359A1
Authority
CA
Canada
Prior art keywords
leu
ala
gly
val
glu
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002366359A
Other languages
English (en)
Inventor
Heike Brotz
Kerstin Ehlert
Christoph Freiberg
Frank Spaltmann
Bernd Wieland
Harald Labischinski
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bayer AG
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2366359A1 publication Critical patent/CA2366359A1/fr
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Biochemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Virology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)

Abstract

L'invention concerne des acides nucléiques et leurs séquences protéiques dérivées, qui possèdent des fonctions essentielles à la vie d'Escherichia coli; des vecteurs et des cellules hôtes, transformées au moyen desdits vecteurs, qui permettent l'expression desdites protéines essentielles et les protéines produites au moyen desdits vecteurs; ainsi que l'utilisation des protéines produites au moyen desdits vecteurs dans des techniques de criblage qui permettent de rechercher des substances antibactériennes et les substances antibactériennes trouvées au moyen desdites protéines.
CA002366359A 1999-04-10 2000-03-28 Genes bacteriens essentiels et leurs proteines Abandoned CA2366359A1 (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE19916176.3 1999-04-10
DE19916176A DE19916176A1 (de) 1999-04-10 1999-04-10 Neue essentielle bakterielle Gene und ihre Proteine
PCT/EP2000/002713 WO2000061792A1 (fr) 1999-04-10 2000-03-28 Genes bacteriens essentiels et leurs proteines

Publications (1)

Publication Number Publication Date
CA2366359A1 true CA2366359A1 (fr) 2000-10-19

Family

ID=7904106

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002366359A Abandoned CA2366359A1 (fr) 1999-04-10 2000-03-28 Genes bacteriens essentiels et leurs proteines

Country Status (6)

Country Link
EP (1) EP1171629A1 (fr)
JP (1) JP2002541819A (fr)
AU (1) AU4111900A (fr)
CA (1) CA2366359A1 (fr)
DE (1) DE19916176A1 (fr)
WO (1) WO2000061792A1 (fr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6660507B2 (en) 2000-09-01 2003-12-09 E. I. Du Pont De Nemours And Company Genes involved in isoprenoid compound production
KR20040100435A (ko) * 2003-05-23 2004-12-02 (주)대한솔루션 자동차용 적층체 및 그 제조방법과 제조장치
CN110804562B (zh) * 2018-08-02 2024-08-09 广州溯原生物科技股份有限公司 一种头孢抗性且高表达Sir2样蛋白的粪肠球菌及应用

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5858367A (en) * 1997-03-27 1999-01-12 Case Western Reserve University Methods for screening for antimicrobials utilizing AarC and compositions thereof
GB9808363D0 (en) * 1998-04-22 1998-06-17 Glaxo Group Ltd Bacterial polypeptide family

Also Published As

Publication number Publication date
JP2002541819A (ja) 2002-12-10
AU4111900A (en) 2000-11-14
EP1171629A1 (fr) 2002-01-16
DE19916176A1 (de) 2000-10-12
WO2000061792A1 (fr) 2000-10-19

Similar Documents

Publication Publication Date Title
Fischetti Surface proteins on Gram‐positive bacteria
JP4852211B2 (ja) 原核生物における必須遺伝子の同定
Ayala et al. Molecular biology of bacterial septation
Hakenbeck et al. [24] Analysis of two-component signal transduction systems involved in transcriptional regulation
US20040029129A1 (en) Identification of essential genes in microorganisms
Bottomley et al. S taphylococcus aureus DivIB is a peptidoglycan‐binding protein that is required for a morphological checkpoint in cell division
AU2009284649B2 (en) Siderophore-mediated iron uptake in bacterial infection
CA2366359A1 (fr) Genes bacteriens essentiels et leurs proteines
Alcorlo et al. Regulation of lytic machineries by the FtsEX complex in the bacterial divisome
Bukowska‐Faniband et al. Transpeptidase activity of penicillin‐binding protein S po VD in peptidoglycan synthesis conditionally depends on the disulfide reductase S to A
Schwabe Secretion and regulation of synthesis of exopolysaccharides in Myxococcus xanthus
Campbell et al. Regulation of bacterial transcription by anti‐σ factors
Zhang et al. Contribution of two-component response regulator OmpR to virulence, motility, exopolysaccharide production, and osmotic stress in Pseudomonas syringae pv. actinidiae
Bhowmick Functional analysis of LCP-LytR_C-domain proteins in c-di-AMP signalling and cell differentiation in Streptomyces
Raynor Functional Similarity of PRD-Containing Virulence Regulators in Bacillus anthracis
Sherman Reconstitution of bacterial lipopolysaccharide transport from purified components
Whitfield Mechanistic and Regulatory Insights into the Biosynthesis of the Pseudomonas aeruginosa Biofilm Exopolysaccharide Pel
Maderbocus A study of outer membrane biogenesis in E. coli
Habib Role of carbohydrate metabolism in cell wall biosynthesis and multicellular development in Bacillus subtilis
Sanchez Insights Into The Reactivation, Regulation And Essentiality Of Oxidative Protein Folding Pathways In Actinobacteria
Gancayco Mutations of the glucose-pts in sublancin-resistant B. subtilis 168 ΔSPΒ
Weiß Functional analysis of the ubiquitously conserved protein GCP1 from Escherichia coli
JP2002506628A (ja) 細菌性ポリペプチドファミリー
Schmidt Regulation of the transition between motile planktonic and sessile biofilm-associated lifestyles in Pseudomonas aeruginosa
Burns Structure-function studies of the PRG K-family of type III secretion proteins

Legal Events

Date Code Title Description
FZDE Dead